The Goal: Find Vaccine Candidates in Neisseria meningitidis

Data derived from the Science Watch/Hot Papers database and the Web of Science (ISI, Philadelphia) show that Hot Papers are cited 50 to 100 times more often than the average paper of the same type and age. Despite the plethora of microbial genome papers, most do little more than catalog genes and analyze results, says Hervé Tettelin, a microbial genomics investigator at the Institute for Genomic Research, Rockville, Md. They normally are presented, he says, as underpinnings for further

Jim Kling
Jul 21, 2002
Data derived from the Science Watch/Hot Papers database and the Web of Science (ISI, Philadelphia) show that Hot Papers are cited 50 to 100 times more often than the average paper of the same type and age.

Despite the plethora of microbial genome papers, most do little more than catalog genes and analyze results, says Hervé Tettelin, a microbial genomics investigator at the Institute for Genomic Research, Rockville, Md. They normally are presented, he says, as underpinnings for further inquiry. But that was not the case when Tettelin and coworkers set out to sequence a serogroup B strain of Neisseria meningitides--their goal was to find vaccine candidates. The resulting Hot Paper "is the first case of a whole genome sequence coming out with a very direct application," he says.1

Neisseria meningitidis lives peacefully in the nasopharynx until unknown factors conspire to make it cross the endothelial cell...

Interested in reading more?

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?